A Study to Investigate Efficacy and Safety With LEO 90100 Compared With Daivobet® Ointment in Adult Chinese Subjects With Stable Plaque Psoriasis
Clinical trial NCT05919082 · COMPLETED
Trial details
- NCT number
- NCT05919082
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-21
- Primary completion
- 2024-02-23
- Enrollment
- 604
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.